NOVC (XETRA) - Novo Nordisk A/S

Exchange: XETRA Exchange • Country: Germany • Currency: EUR • Type: Common Stock • ISIN: DK0060534915
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Rare Disease. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, glucagon, needles, and other chronic diseases. The Rare Disease segment offers products in the areas of haemophilia, blood disorders, endocrine disorders, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for NOVC (XETRA) - Novo Nordisk A/S
  • Uncommon Growth Rate
Market Cap. 339,129m EUR
Enterprise Value 361,370m EUR (+6%)
Sector Healthcare
Industry Biotechnology
TER 0.00%
IPO / Inception


Fundamental 7.51
Dividend 8.13
Technical 9.57
Performance 7.15
Analysts -
Price / Fair Price TR 0.78
Price / Fair Price DCF todo


Growth TTM 61.75%
CAGR 5y 50.34%
CAGR / Mean Drawdown 5y 12.02
Sharpe Ratio TTM 2.17
Alpha vs SP500 TTM 58.52
Beta vs SP500 5y weekly 0.60
Volatility GJR Garch 1y 29.41%
CAPM 7.89%
Correlation TTM 0.82
Max Drawdown 5y 21%
Mean Drawdown 5y 4.2%
Price / SMA 200 days -21.39%
Current Volume 23.1k
Average Volume 22.6k


Rate TTM 12.40
Yield TTM 8.13%
Div. CAGR 5y 7.27%
Consistency of Dividends all time 97.2%